Antivirals Linked to Lower Hospitalization in Influenza
Matched cohort study in nonhospitalized patients
-
By
-
Kathryn Wighton
-
April 13, 2026
-
Clinical Scorecard: Antivirals Linked to Lower Hospitalization in Influenza
At a Glance
| Category | Detail |
|---|
| Condition | Influenza |
| Key Mechanisms | Antiviral treatment reduces hospitalization, ICU admission, and mortality rates. |
| Target Population | Nonhospitalized patients with laboratory-confirmed influenza. |
| Care Setting | Multicenter retrospective cohort study using electronic health records. |
Key Highlights
- Antiviral treatment within 2 days of diagnosis linked to lower hospitalization rates.
- Hospitalization rates: 1.54% in treated vs 1.70% in untreated patients.
- Significant reductions in emergency department visits and ICU admissions.
- Oseltamivir showed consistent benefits across outcomes.
- Subgroup analysis indicated lower risks in adults and pediatric patients.
Guideline-Based Recommendations
Diagnosis
- Laboratory confirmation of influenza is essential before treatment.
Management
- Initiate antiviral therapy within 2 days of diagnosis for optimal outcomes.
Monitoring & Follow-up
- Assess hospitalization and ICU admission rates post-treatment.
Risks
- Consider potential unmeasured confounding and limitations in data.
Patient & Prescribing Data
Nonhospitalized patients aged 2 to 64 years without high-risk comorbidities.
Oseltamivir and baloxavir are effective; other antivirals showed no significant benefits.
Clinical Best Practices
- Administer antivirals promptly within 2 days of influenza diagnosis.
- Monitor for potential complications and hospitalization post-treatment.
- Consider patient age and comorbidities when prescribing antivirals.
Related Resources & Content
